tiprankstipranks
Advertisement
Advertisement

HK:9606 Stock Latest News

Duality Biotherapeutics Wins China BLA Acceptance for Key HER2 Breast Cancer Drug
Company AnnouncementsDuality Biotherapeutics Wins China BLA Acceptance for Key HER2 Breast Cancer Drug
2d ago
9606
Duality Biotherapeutics Sets April 29, 2026 Extraordinary General Meeting and Book Closure Dates
PremiumCompany Announcements
Duality Biotherapeutics Sets April 29, 2026 Extraordinary General Meeting and Book Closure Dates
2d ago
9606
Duality Biotherapeutics: Strong ADC Portfolio and Upcoming Catalysts Support Upside and Maintain Buy Rating
PremiumRatings
Duality Biotherapeutics: Strong ADC Portfolio and Upcoming Catalysts Support Upside and Maintain Buy Rating
12d ago
Duality Biotherapeutics Narrows Adjusted Loss as Lead ADCs Hit Key Clinical Milestones
PremiumCompany Announcements
Duality Biotherapeutics Narrows Adjusted Loss as Lead ADCs Hit Key Clinical Milestones
19d ago
9606
Duality Biotherapeutics Reshapes Board and Finance Leadership to Back R&D Strategy
PremiumCompany Announcements
Duality Biotherapeutics Reshapes Board and Finance Leadership to Back R&D Strategy
19d ago
9606
Duality Biotherapeutics Details Board and Committee Structure
PremiumCompany AnnouncementsDuality Biotherapeutics Details Board and Committee Structure
19d ago
9606
Duality Biotherapeutics Sets March Board Meeting on 2025 Results and Dividend
Premium
Company Announcements
Duality Biotherapeutics Sets March Board Meeting on 2025 Results and Dividend
1M ago
9606
Duality Biotherapeutics Reports Encouraging Prostate Cancer Data for Lead ADC at ASCO GU 2026
Premium
Company Announcements
Duality Biotherapeutics Reports Encouraging Prostate Cancer Data for Lead ADC at ASCO GU 2026
2M ago
9606
Duality Biotherapeutics Shareholders Approve 2025 Equity Incentive Scheme and Mandate Limits
PremiumCompany Announcements
Duality Biotherapeutics Shareholders Approve 2025 Equity Incentive Scheme and Mandate Limits
3M ago
9606
Duality Biotherapeutics Proposes 2025 Share Scheme to Boost Growth
PremiumCompany Announcements
Duality Biotherapeutics Proposes 2025 Share Scheme to Boost Growth
4M ago
9606
Duality Biotherapeutics Announces EGM for 2025 Share Scheme Approval
PremiumCompany Announcements
Duality Biotherapeutics Announces EGM for 2025 Share Scheme Approval
4M ago
9606
Duality Biotherapeutics Announces Extraordinary General Meeting
PremiumCompany Announcements
Duality Biotherapeutics Announces Extraordinary General Meeting
4M ago
9606
Duality Biotherapeutics Plans RMB Share Listing on Shanghai’s Sci-Tech Board
PremiumCompany AnnouncementsDuality Biotherapeutics Plans RMB Share Listing on Shanghai’s Sci-Tech Board
6M ago
9606
Duality Biotherapeutics Gains Inclusion in Key Stock Indices
Premium
Company Announcements
Duality Biotherapeutics Gains Inclusion in Key Stock Indices
7M ago
9606
Duality Biotherapeutics Achieves Key Milestone in Cancer Drug Trial
Premium
Company Announcements
Duality Biotherapeutics Achieves Key Milestone in Cancer Drug Trial
7M ago
9606
Duality Biotherapeutics, Inc.: Strong Growth Potential and Innovation Drive Buy Rating
PremiumRatings
Duality Biotherapeutics, Inc.: Strong Growth Potential and Innovation Drive Buy Rating
7M ago
Duality Biotherapeutics Reports Strong Pipeline Progress Amid Financial Losses
PremiumCompany Announcements
Duality Biotherapeutics Reports Strong Pipeline Progress Amid Financial Losses
8M ago
9606
Duality Biotherapeutics Schedules Board Meeting for Interim Results
PremiumCompany Announcements
Duality Biotherapeutics Schedules Board Meeting for Interim Results
8M ago
9606
Duality Biotherapeutics’ DB-1310 Receives FDA Fast Track Designation
PremiumCompany Announcements
Duality Biotherapeutics’ DB-1310 Receives FDA Fast Track Designation
9M ago
9606
Duality Biotherapeutics Secures Shareholder Approval for Key Resolutions at AGM
PremiumCompany AnnouncementsDuality Biotherapeutics Secures Shareholder Approval for Key Resolutions at AGM
10M ago
9606
Duality Biotherapeutics Addresses Stock Fluctuations Post-Data Release
Premium
Company Announcements
Duality Biotherapeutics Addresses Stock Fluctuations Post-Data Release
10M ago
9606
Promising Investment Opportunity in Duality Biotherapeutics: Strong ADC Pipeline and Strategic Partnerships Justify Buy Rating
Premium
Ratings
Promising Investment Opportunity in Duality Biotherapeutics: Strong ADC Pipeline and Strategic Partnerships Justify Buy Rating
10M ago

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >